A U.S. study of over 500 youth aged 14–24 found high awareness but widespread hesitation about using semaglutide for weight loss. Concerns focused on safety, social stigma, and a preference for lifestyle changes like diet and exercise.
What’s behind Gen Z’s skepticism about Ozempic and Wegovy
- Post author:admin
- Post published:April 24, 2025
- Post category:uncategorized
- Post comments:0 Comments